Increased EMMPRIN and MT1-MMP levels in the plasma of the stable adult patients with cystic fibrosis

S. Jouneau, G. Leveiller, B. Desrues, V. Lagente, C. Martin-Chouly (Rennes, France)

Source: Annual Congress 2005 - Cystic fibrosis: genes, inflammation and more
Session: Cystic fibrosis: genes, inflammation and more
Session type: Thematic Poster Session
Number: 2579

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Jouneau, G. Leveiller, B. Desrues, V. Lagente, C. Martin-Chouly (Rennes, France). Increased EMMPRIN and MT1-MMP levels in the plasma of the stable adult patients with cystic fibrosis. Eur Respir J 2005; 26: Suppl. 49, 2579

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
KL-6 serum levels in adult cystic fibrosis patients
Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies
Year: 2011

Differential expression of IL-33 and HMGB1 in the lungs of stable cystic fibrosis patients
Source: Eur Respir J 2014; 44: 802-805
Year: 2014


Increased expression of MMP-2 in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 361s
Year: 2005

Serum levels of TIMP-1 and TIMP-2 are elevated in patients with pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 463s
Year: 2003

Are there serum levels of MMP-2 and MMP-9 may be markers of COPD phenotypes?
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012


Increased concentration of matrix metalloproteinase-9 in serum of COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 54s
Year: 2005

Sputum and plasma adiponectin levels in clinically stable adult cystic fibrosis patients with CFTR I1234V mutation
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018


Progression of monocrotaline-induced pulmonary hypertension in rats can be monitored by plasma activity of matrix metalloproteinase-2 and plasma levels of tenascin-C and proBNP
Source: Eur Respir J 2007; 30: Suppl. 51, 7s
Year: 2007

Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis
Source: Eur Respir J 2015; 46: 384-394
Year: 2015



Altered expression of adhesion molecules in circulating neutrophils of patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2002; 20: Suppl. 38, 479s
Year: 2002

Decreased BCL-2 expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010


Increased epithelial production of LPLUNC1 in cystic fibrosis lung disease
Source: Annual Congress 2011 - Epithelial cell biology
Year: 2011


Increased intraalveolar level of soluble endothelial protein C receptor in patients with interstitial lung disease
Source: Eur Respir J 2004; 24: Suppl. 48, 319s
Year: 2004

Elevated serum LOXL2 levels are associated with rapid disease progression in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012

Relation of serum IGF-1 and IGFBP3 levels with acute exacerbation in cystic fibrosis
Source: International Congress 2018 – Clinical problems in paediatric pulmonology
Year: 2018

Circulating matrix metalloproteinase-9 (MMP-9) is associated with the extension of lung disease in patients with active tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 35s
Year: 2004

Increased polysialylation in lung tissue of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - Cell biology of lung disease
Year: 2011


MMP expression and abnormal lung permeability are important determinants of outcome in IPF
Source: Eur Respir J 2009; 33: 77-84
Year: 2009



Serum lipid concentrations and malnutrition in adult cystic fibrosis patients
Source: Eur Respir J 2006; 28: Suppl. 50, 58s
Year: 2006

Decreased levels of secretory leucoprotease inhibitor in the pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009